Please join us for Xconomy Forum's New England's Emerging Biotech Stars, taking place April 4, 2012 at Biogen Idec, in Cambridge, MA.
The New England biotech hub has been on a roll the past couple years, with the breakout success of Vertex Pharmaceuticals, the ongoing revival at Biogen Idec, Sanofi's $20 billion acquisition of Genzyme, and the continuing concentration of Big Pharma R&D in Boston. But both the science and business of biotech move fast. So which companies, and which entrepreneurs, are the ones to watch for the next five to 10 years? We'll have keynotes from two of Boston's biotech leaders. We'll hear from the CEOs of five biotech startups that are gaining traction in the industry. And we'll have an interactive panel discussion about an important but sometimes overlooked source of startup funding: grants from non-profit disease foundations. Join us for this extraordinary gathering of up-and-comers in the New England biotech hub.
Keynote speakers:
George Scangos, CEO, Biogen
Mark Levin, Partner, Third Rock Ventures
Featured Speakers:
Chip Clark, CEO, Genocea
Doug Fambrough, CEO, Dicerna
Tillman Gerngross, CEO, Adimab
Joanna Horobin, CEO, Syndax
Joseph Yanchik, CEO, Aileron
Louise Perkins, Chief Scientific Officer, Multiple Myeloma Foundation
Julia Greenstein, Assistant Vice President, Cure Therapies, Juvenile Diabetes Research Foundation
Dana Callow, Managing General Partner, Boston Millennia Partners; Board Member, Leukemia & Lymphoma Society
Michael Kauffman, CEO, Karyopharm
Schedule:
Registration: 12:30 – 1:30 pm
Program: 1:30 – 5:30 pm
Networking Reception: 5:30 – 6:30 pm
To register and for more information, please click here.